Day: March 4, 2024

Atlanticus Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth Quarter 2023 Operating revenue growth of 14.9% over prior year, with 3.6 million accounts served (1), allowing for continued strong results Source: Atlanticus Holdings Corp ATLANTA, March 04, 2024 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (Atlanticus, the Company, we, our or us), a financial technology company which enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced its financial results for the fourth quarter and full year ended December 31, 2023. An accompanying earnings presentation is available in the Investors section of the Company’s website at www.atlanticus.com or by clicking here. Financial and Operating Highlights Fourth Quarter 2023 Highlights (all comparisons to the Fourth Quarter 2022) Managed...

Continue reading

Diversified Royalty Corp. Announces March 2024 Cash Dividend and Q4 2023 Earnings Release Date

VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to confirm that DIV’s annual dividend has increased from 24.5 cents per share to 25.0 cents per share effective March 1, 2024 as previously announced on February 14, 2024. In accordance with the dividend increase, DIV is pleased to announce that its board of directors has approved a cash dividend of $0.02083 per common share for the period of March 1, 2024 to March 31, 2024, which is equal to $0.25 per common share on an annualized basis. The dividend will be paid on March 28, 2024 to shareholders of record as of the close of business on March 15, 2024. Q4 2023 Earnings Release Date DIV will release earnings results for the three months and year ended December 31, 2023 following...

Continue reading

Intapp Announces Launch of Secondary Offering of Common Stock

PALO ALTO, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Intapp, Inc. (NASDAQ: INTA) (the “Company”), a leading global provider of AI-powered software for professionals in advisory, legal, and capital markets firms, today announced that certain entities affiliated with Great Hill Equity Partners IV, L.P. (together with its affiliates, the “Selling Stockholder”) intend to offer an aggregate of 7,000,000 shares of the Company’s common stock in an underwritten public offering (the “Offering”). The Selling Stockholder will receive all of the proceeds from the Offering. The Company will not sell any shares of its common stock in the Offering and will not receive any proceeds from the sale by the Selling Stockholder of shares of the Company’s common stock in the Offering. The Company’s common stock is listed on the Nasdaq Global Select Market...

Continue reading

Brookfield Announces Reset Dividend Rate on its Series 34 Preference Shares

BROOKFIELD, NEWS, March 04, 2024 (GLOBE NEWSWIRE) — Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced that it has determined the fixed dividend rate on its Cumulative Class A Preference Shares, Series 34 (“Series 34 Shares”) (TSX: BN.PF.B) for the five years commencing April 1, 2024 and ending March 31, 2029. If declared, the fixed quarterly dividends on the Series 34 Shares during the five years commencing April 1, 2024 will be paid at an annual rate of 6.145% ($0.3840625 per share per quarter). Holders of Series 34 Shares have the right, at their option, exercisable not later than 5:00 p.m. (Toronto time) on March 18, 2024, to convert all or part of their Series 34 Shares, on a one-for-one basis, into Cumulative Class A Preference Shares, Series 35 (the “Series 35 Shares”), effective March 31, 2024. The...

Continue reading

German American Bank Announces Scott Powell as Chief Credit Officer

JASPER, Ind., March 04, 2024 (GLOBE NEWSWIRE) — German American Bancorp, Inc. (Nasdaq: GABC) and its banking subsidiary, German American Bank, announces that Scott Powell has been appointed Executive Vice President, Chief Credit Officer, effective April 1, 2024. Powell will succeed current Executive Vice President and Chief Credit Officer, Keith A. Leinenbach, who will be retiring. Leinenbach will retire after 24 years with the organization and over 40 years of broad-based banking industry experience. Keith has been a trusted steward of German American’s credit culture for decades and has provided exceptional executive leadership over the years. Neil Dauby, Chairman and CEO, states, “We wish Keith well in his retirement years and thank him for his dedicated leadership and service to our customers, employees, shareholders and communities....

Continue reading

Tim Lamb Group Brings Two Families Together with Sale of Foothills Lincoln Mazda in Spokane, WA

Sold to Eve Knudtsen President and Owner of Knudtsen Chevrolet Tim Wild with Tim Lamb Group Closes the Sale of Foothills Lincoln Mazda Tim Lamb Group Closes the Sale of Foothills Lincoln Mazda Dealership in Spokane, WA. Photo Credit Tim Lamb Group Pictured Left to Right: Lauren Benedict (Knudtsen Chevrolet), Tim Wild (Tim Lamb Group), Rick Rielly (Foothills Lincoln Mazda), Eve Knudtsen (Knudtsen Chevrolet), and Ray Kish (Foothills Lincoln Mazda) Columbus, OH, March 04, 2024 (GLOBE NEWSWIRE) — Tim Wild, Director at the Tim Lamb Group, the largest auto dealership sales, and acquisitions firm in North America, has brokered the sale of Foothills Lincoln Mazda owned by Rick Rielly and Ray Kish to Eve Knudtsen President and Owner of Knudtsen Chevrolet. The deal, facilitated by Wild closed on February 15, 2024. Foothills Lincoln...

Continue reading

Akero Therapeutics Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced today that it has commenced an underwritten public offering of $300.0 million of shares of its common stock. All of the shares in the proposed offering are being offered by Akero Therapeutics. In addition, Akero Therapeutics intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of shares of its common stock at the public offering price, less underwriting discounts and commissions. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to...

Continue reading

Priority Income Fund Reaches 10 Year Anniversary and Announces 11.3% Annualized Total Cash Distribution Rate (on Class R Offering Price) with New “Bonus” and “Base” Common Shareholder Distributions for March through May 2024

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — Priority Income Fund, Inc. (“Priority Income Fund” or the “Fund”), which has now reached its 10th year anniversary as an important milestone, announced today that the Fund’s Board of Directors has declared monthly cash “base” and “bonus” common shareholder distributions for March 2024, April 2024 and May 2024. The annualized total cash distribution is $1.34016 per share (11.3% annualized rate for Class R and 12.1% annualized rate for Class I), for distributions with record dates between March 5, 2024 and May 3, 2024 based on the current Class R offering price of $11.91 per common share and the current Class I offering price of $11.11 per common share. The cash “base” distribution will have monthly record dates and will be payable monthly to common stockholders of record at the close of...

Continue reading

BridgeBio Pharma Announces Proposed Public Offering of Common Stock

PALO ALTO, Calif., March 04, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced today that it has commenced an underwritten public offering of $250 million of shares of its common stock. BridgeBio also intends to grant the underwriters a 30-day option to purchase up to an additional $37.5 million of shares of its common stock. All of the shares in the proposed offering are to be sold by BridgeBio. J.P. Morgan, Cantor Fitzgerald & Co. and Mizuho are acting as joint book-running managers for the proposed offering. Raymond James is acting as lead manager. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as...

Continue reading

CPS Technologies Announces MMAP Award

NORTON, Mass., March 04, 2024 (GLOBE NEWSWIRE) — CPS Technologies Corporation (NASDAQ:CPSH) (“CPS” or the “Company”) today announced it has received an award from the Massachusetts Manufacturing Accelerate Program (“MMAP”) in response to a proposal submitted by the Company in the fourth quarter of 2023. The award, valued at $200,000, will support the purchase of a 5-axis CNC machine and expand the Company’s manufacturing capabilities to better serve its clients. This new capability will build on the Company’s core competencies while enabling CPS to fulfill a new generation of customer requirements and capture additional business. The addition of a 5-axis CNC machine will also allow the Company to complete more work in the Commonwealth of Massachusetts and, more specifically, in-house. With this increased manufacturing capacity,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.